Phase II randomized trial of vinorelbine and gemcitabine versus carboplatin and paclitaxel in advanced non-small-cell lung cancer
Lilenbaum, R. C., Chen, C.-S., Chidiac, T., Schwarzenberger, P. O., Thant, M., Versola, M., Lane, S. R.
Published in Annals of oncology (01.01.2005)
Published in Annals of oncology (01.01.2005)
Get full text
Journal Article
Phase I study of paclitaxel and topotecan in patients with advanced tumors: a cancer and leukemia group B study
Lilenbaum, R C, Ratain, M J, Miller, A A, Hargis, J B, Hollis, D R, Rosner, G L, O'Brien, S M, Brewster, L, Green, M R, Schilsky, R L
Published in Journal of clinical oncology (01.09.1995)
Published in Journal of clinical oncology (01.09.1995)
Get more information
Journal Article
Stage IIIA category of non-small-cell lung cancer: a new proposal
Green, M R, Lilenbaum, R C
Published in JNCI : Journal of the National Cancer Institute (20.04.1994)
Published in JNCI : Journal of the National Cancer Institute (20.04.1994)
Get more information
Journal Article
Issues at the cutting edge in stage III non-small-cell lung cancer
Get full text
Journal Article
Conference Proceeding
Phase I study of paclitaxel and etoposide for metastatic or recurrent malignancies
Lilenbaum, R C, MacManus, D, Engstrom, C, Green, M
Published in American journal of clinical oncology (01.04.1998)
Published in American journal of clinical oncology (01.04.1998)
Get more information
Journal Article
Interleukin 2-induced focal fatty infiltrate of the liver that mimics metastases
Lilenbaum, R C, Lilenbaum, A M, Hryniuk, W M
Published in JNCI : Journal of the National Cancer Institute (19.04.1995)
Published in JNCI : Journal of the National Cancer Institute (19.04.1995)
Get more information
Journal Article
Interim safety results from the phase 2 ABOUND.PS2 study evaluating nab-paclitaxel (nab-P) + carboplatin (C) followed by nab-P monotherapy in patients (pts) with NSCLC and an Eastern Cooperative Oncology Group (ECOG) performance status (PS) 2
Gajra, A., Ali, H., Amiri, K.I., Karim, N. Abdel, Matrana, M.R., Mulford, D., Ong, T.J., Sanford, A., Santos, E., Socinski, M., Spigel, D.R., Lilenbaum, R.C.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Phase I and pharmacologic study of continuous infusion topotecan in combination with cisplatin in patients with advanced cancer: a Cancer and LeukemiaGroup B study
Lilenbaum, R C, Miller, A A, Batist, G, Bernard, S, Hollis, D R, Rosner, G L, Egorin, M J, Schilsky, R L, Ratain, M J
Published in Journal of clinical oncology (01.10.1998)
Published in Journal of clinical oncology (01.10.1998)
Get more information
Journal Article
Treatment-related fatal sepsis from topotecan/cisplatin and topotecan/paclitaxel
Miller, A A, Lilenbaum, R C, Lynch, T J, Rosner, G L, Ratain, M J, Green, M R, Schilsky, R L
Published in Journal of clinical oncology (01.06.1996)
Published in Journal of clinical oncology (01.06.1996)
Get more information
Journal Article
Single-Agent Versus Combination Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The Cancer and Leukemia Group B (study 9730)
Lilenbaum, Rogerio C, Herndon, 2nd, James E, List, Marcy A, Desch, Chris, Watson, Dorothy M, Miller, Antonius A, Graziano, Stephen L, Perry, Michael C, Saville, Wayne, Chahinian, Philippe, Weeks, Jane C, Holland, Jimmie C, Green, Mark R
Published in Journal of clinical oncology (01.01.2005)
Published in Journal of clinical oncology (01.01.2005)
Get full text
Journal Article